Health System Delay in Treatment of Multidrug Resistant Tuberculosis Patients in Bangladesh

BMC Infectious Diseases - United Kingdom
doi 10.1186/s12879-015-1253-9
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Pre-Extensively Drug Resistant Tuberculosis (Pre-XDR-Tb) Among Pulmonary Multidrug Resistant Tuberculosis (MDR-TB) Patients in Bangladesh

Journal of Tuberculosis Research
2018English

Fluoroquinolone Resistance in Multidrug-Resistant Tuberculosis Patients

Korean Journal of Internal Medicine
Internal Medicine
2019English

Hypokalemia Among Patients Receiving Treatment for Multidrug-Resistant Tuberculosis

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2004English

Predictors of Unfavourable Treatment Outcome in Patients With Multidrug-Resistant Tuberculosis in India

Public Health Action
Health PolicyPublic HealthOccupational HealthEnvironmental
2017English

Reducing Harm in the Treatment of Multidrug-Resistant Tuberculosis

The Lancet
Medicine
2018English

Recurrence After Successful Treatment of Multidrug-Resistant Tuberculosis in Taiwan

PLoS ONE
Multidisciplinary
2017English

Multidrug Resistant Tuberculosis

British Medical Journal
Medicine
2015English

Trends in Multidrug-Resistant Tuberculosis

Journal of Venomous Animals and Toxins Including Tropical Diseases
Animal ScienceZoologyParasitologyInfectious DiseasesToxicology
2008English

Clofazimine for the Treatment of Multidrug-Resistant Tuberculosis

Clinical Microbiology and Infection
MedicineInfectious DiseasesMicrobiology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy